CD4 and melanoma: A prior study reported that there was divergent DNAM-1 expression in Tregs and CD4+ effector T cells in melanoma patient TILs, demonstrating that different mechanisms are involved in regulating DNAM-1 expression in different functional T cell subsets [13].